Smoking impact on CYP1A2 activity in a group of patients with schizophrenia

VP Bozikas, M Papakosta, I Niopas, A Karavatos… - European …, 2004 - Elsevier
The purpose of the present study was to assess the impact of smoking on the metabolism of
psychotropic drugs in a group of patients with schizophrenia, by measuring CYP1A2 activity …

Smoking impact on CYP1A2 activity in a group of patients with schizophrenia

VP Bozikas, M Papakosta, I Niopas… - European …, 2004 - infona.pl
The purpose of the present study was to assess the impact of smoking on the metabolism of
psychotropic drugs in a group of patients with schizophrenia, by measuring CYP1A2 activity …

Smoking impact on CYP1A2 activity in a group of patients with schizophrenia.

VP Bozikas, M Papakosta, I Niopas… - … : the Journal of the …, 2004 - europepmc.org
The purpose of the present study was to assess the impact of smoking on the metabolism of
psychotropic drugs in a group of patients with schizophrenia, by measuring CYP1A2 activity …

[引用][C] Smoking impact on CYP1A2 activity in a group of patients with schizophrenia

VP BOZIKAS - Eur. Neuropsychopharmacol, 2004 - cir.nii.ac.jp

Smoking impact on CYP1A2 activity in a group of patients with schizophrenia

VP Bozikas, M Papakosta, I Niopas… - … : the journal of the …, 2004 - pubmed.ncbi.nlm.nih.gov
The purpose of the present study was to assess the impact of smoking on the metabolism of
psychotropic drugs in a group of patients with schizophrenia, by measuring CYP1A2 activity …

[引用][C] Smoking impact on CYP1A2 activity in a group of patients with schizophrenia

VP Bozikas, M Papakosta, I Niopas… - European …, 2004 - cir.nii.ac.jp
Smoking impact on CYP1A2 activity in a group of patients with schizophrenia | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文 …